Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy

S Lebdai , R Mathieu , J Leger , O Haillot , S Vincendeau , N Rioux-Leclercq (1) , G Fournier , Ma Perrouin-Verbe , L Doucet , Ar Azzouzi , J Rigaud , K Renaudin , T Charles , F Bruyere , G. Fromont

1 Irset - Institut de recherche en santé, environnement et travail

Domains: Life Sciences [q-bio]; Cancer

S Lebdai, R Mathieu, J Leger, O Haillot, S Vincendeau, et al.. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy. Seminars in Urologic Oncology, 2018, 36 (2), pp.17-24. ⟨hal-02454322⟩